Cheol-Hee Yoon

5PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Biologically active moleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 20, 2025
ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation.

Jeong Eun Kang, Hyun Wook Seo, Dong-Eun Kim

|Oct 08, 2021
Transcriptome Analysis Identifies Altered Biological Processes and Novel Markers in Human Immunodeficiency Virus-1 Long-Term Non-Progressors.

Dayeon Lee, Cheol-Hee Yoon, Sin Young Choi

|Aug 12, 2020
Identification of Aristolactam Derivatives That Act as Inhibitors of Human Immunodeficiency Virus Type 1 Infection and Replication by Targeting Tat-Mediated Viral Transcription.

YoungHyun Shin, Chul Min Park, Hong Gi Kim

|Aug 17, 2016
Highly activated p53 contributes to selectively increased apoptosis of latently HIV-1 infected cells upon treatment of anticancer drugs.

YoungHyun Shin, Hoyong Lim, Byeong-Sun Choi

|Mar 12, 2014
Characterization of Gp41 polymorphisms in the fusion peptide domain and T-20 (Enfuvirtide) resistance-associated regions in Korean HIV-1 isolates.

Dai-Ho Jang, Cheol-Hee Yoon, Byeong-Sun Choi

Pageof 1

Frequent Collaborators

2 joint publications

Byeong-Sun Choi

1 joint publications

Dai-Ho Jang

1 joint publications

Yoon-Seok Chung

1 joint publications

Hye-Young Kim